These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26311039)

  • 1. An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect.
    Liu YH; Bu XL; Liang CR; Wang YR; Zhang T; Jiao SS; Zeng F; Yao XQ; Zhou HD; Deng J; Wang YJ
    J Neuroinflammation; 2015 Aug; 12():153. PubMed ID: 26311039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
    Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
    Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia.
    Morkuniene R; Zvirbliene A; Dalgediene I; Cizas P; Jankeviciute S; Baliutyte G; Jokubka R; Jankunec M; Valincius G; Borutaite V
    J Neurochem; 2013 Sep; 126(5):604-15. PubMed ID: 23745639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
    Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
    J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies.
    Wacker J; Rönicke R; Westermann M; Wulff M; Reymann KG; Dobson CM; Horn U; Crowther DC; Luheshi LM; Fändrich M
    Acta Neuropathol Commun; 2014 Apr; 2():43. PubMed ID: 24725347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic implications of gelsolin in Alzheimer's disease.
    Ji L; Zhao X; Hua Z
    J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
    Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
    J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level.
    Deng J; Liu B; Tao Q; Luo Y; Zhu Y; Huang X; Yue F
    Neuroscience; 2024 May; 547():37-55. PubMed ID: 38604526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.
    Wang F; Zhou XL; Yang QG; Xu WH; Wang F; Chen YP; Chen GH
    PLoS One; 2011; 6(11):e27649. PubMed ID: 22102917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells.
    Ill-Raga G; Ramos-Fernández E; Guix FX; Tajes M; Bosch-Morató M; Palomer E; Godoy J; Belmar S; Cerpa W; Simpkins JW; Inestrosa And NC; Muñoz FJ
    J Alzheimers Dis; 2010; 22(2):641-52. PubMed ID: 20858976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.